Accelerated partial breast irradiation in elderly breast cancer patients.

Accelerated brachytherapy breast cancer elderly radiotherapy

Journal

Translational cancer research
ISSN: 2219-6803
Titre abrégé: Transl Cancer Res
Pays: China
ID NLM: 101585958

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 21 05 2019
accepted: 27 06 2019
entrez: 4 2 2022
pubmed: 1 1 2020
medline: 1 1 2020
Statut: ppublish

Résumé

Breast-conserving surgery with adjuvant whole-breast irradiation has become the standard treatment for early breast cancer (EBC) patients. Partial breast irradiation, which targets only the postoperative cavity, has been established as an alternative to whole-breast therapy in selected patients. The treatment of elderly breast cancer patients differs from the therapeutic approach in younger ones, as elderly patients are prone to geriatric frailty and comorbid conditions, the incidence and severity of which increase with age. A review of the evidence, process, techniques, and results of accelerated partial breast irradiation (APBI) in elderly EBC patients, seems to indicate that APBI is an advisable postoperative approach in properly selected elderly EBC patients, combining advantages of a radical approach that minimizes the risk of undertreatment with efficient reduction of redundant irradiated volume, treatment toxicity, overall treatment time, staff workload, radiation technique workflow, patient transportation, and the potential for non-compliance. There is no "one size fits all" technique of APBI, the best technique always depending on willing patients, individual anatomy, performance status, patient frailty and comorbid conditions, and tumour location.

Identifiants

pubmed: 35117946
doi: 10.21037/tcr.2019.07.03
pii: tcr-09-S1-S29
pmc: PMC8798666
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

S29-S36

Informations de copyright

2020 Translational Cancer Research. All rights reserved.

Références

Lancet. 2016 Jan 16;387(10015):229-38
pubmed: 26494415
Eur J Cancer. 2015 Mar;51(4):451-463
pubmed: 25605582
Radiother Oncol. 2013 Aug;108(2):197-202
pubmed: 23742961
Brachytherapy. 2017 Sep - Oct;16(5):929-934
pubmed: 28697858
Lancet Oncol. 2015 Mar;16(3):266-73
pubmed: 25637340
Radiother Oncol. 2018 Sep;128(3):411-420
pubmed: 29691075
Eur J Cancer Care (Engl). 2015 Mar;24(2):163-78
pubmed: 25657076
Lancet. 2014 Feb 15;383(9917):603-13
pubmed: 24224997
J Clin Oncol. 2012 Aug 10;30(23):2837-43
pubmed: 22734034
Am J Clin Oncol. 2018 Oct;41(10):986-991
pubmed: 28787281
Brachytherapy. 2013 Jul-Aug;12(4):285-92
pubmed: 23415050
Eur J Cancer. 2013 Jul;49(10):2294-302
pubmed: 23523089
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):259-265
pubmed: 27478165
Radiother Oncol. 2018 Sep;128(3):428-433
pubmed: 29914648
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
J Clin Oncol. 2013 Nov 10;31(32):4038-45
pubmed: 23835717
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):987-1001
pubmed: 19545784
Radiother Oncol. 2010 Mar;94(3):264-73
pubmed: 20181402
Cochrane Database Syst Rev. 2016 Jul 18;7:CD007077
pubmed: 27425375
Ann Oncol. 2014 Nov;25(11):2134-2146
pubmed: 24625455
Brachytherapy. 2018 Nov - Dec;17(6):949-955
pubmed: 30227977
J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11
pubmed: 21719777
J Clin Oncol. 2013 Jul 1;31(19):2382-7
pubmed: 23690420
Brachytherapy. 2013 Jul-Aug;12(4):267-77
pubmed: 23619524
Brachytherapy. 2016 Jul-Aug;15(4):485-494
pubmed: 27129410
Brachytherapy. 2013 Jul-Aug;12(4):293-302
pubmed: 23477884
Breast. 2007 Dec;16 Suppl 2:S89-97
pubmed: 17719226
Breast Cancer Res Treat. 2015 Oct;153(3):539-47
pubmed: 26350524
J Natl Cancer Inst. 2001 Sep 5;93(17):1344-6
pubmed: 11535710
Radiother Oncol. 2015 Jun;115(3):342-8
pubmed: 26104975
Lancet Oncol. 2013 Dec;14(13):1269-77
pubmed: 24225155
Brachytherapy. 2018 Mar - Apr;17(2):407-414
pubmed: 29254856
Breast. 2016 Aug;28:178-83
pubmed: 27322859
Lancet. 2017 Sep 9;390(10099):1048-1060
pubmed: 28779963
Radiother Oncol. 2015 Jan;114(1):42-9
pubmed: 25480094
JAMA Oncol. 2018 Jan 1;4(1):128-129
pubmed: 29098266

Auteurs

Igor Sirák (I)

Department of Oncology and Radiotherapy, University Hospital and Medical Faculty, Hradec Králové, Czech Republic.

Miroslav Hodek (M)

Department of Oncology and Radiotherapy, University Hospital and Medical Faculty, Hradec Králové, Czech Republic.

Pavel Jandík (P)

Department of Surgery, University Hospital, Hradec Králové, Czech Republic.

Jakub Grepl (J)

Department of Oncology and Radiotherapy, University Hospital and Medical Faculty, Hradec Králové, Czech Republic.

Petr Paluska (P)

Department of Oncology and Radiotherapy, University Hospital and Medical Faculty, Hradec Králové, Czech Republic.

Jiří Petera (J)

Department of Oncology and Radiotherapy, University Hospital and Medical Faculty, Hradec Králové, Czech Republic.

Classifications MeSH